Astraveus
About Astraveus
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Non-dilutive T: - FT: Non-dilutive |
A: 7100000 MR: - FA: €7.1M FAN: 7100000 |
D: 2024-12-19 FD: 2024-12-19 |
1 investors |
| 2 |
RT: Series Seed T: - FT: Series Seed |
A: 18000000 MR: - FA: €16.5 million FAN: 18000000 |
D: 2023-06-27 FD: 2023-06-27 |
4 investors |
Growth Metrics
Team & Leadership
Jérôme Larghero
Professor of Cell and Gene Therapies
Tara Clark
Cell & Gene Therapy Commercialization
Jérémie Laurent
CEO and Founder
Didier Masson
Chief Operating Officer
Lars H. Peeck
Chief Business Officer
Laurence Riot Lamotte
Chief Financial Officer
Recent News
Astraveus Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- astraveus.com
- Industries
- Biotechnology
- Company Size
- ~1K employees (est.)
- Locations
- Paris, France
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro